Temozolomide-associated myelodysplasia 6 years after treatment of a patient with pancreatic neuroendocrine tumor.
作者信息
Rashidi Armin, Sorscher Steven M
机构信息
a Division of Oncology, Washington University School of Medicine , St. Louis , MO , USA.
出版信息
Leuk Lymphoma. 2015;56(8):2468-9. doi: 10.3109/10428194.2014.999327. Epub 2015 Jan 21.
PMID:25530344
Abstract
摘要
相似文献
1
Temozolomide-associated myelodysplasia 6 years after treatment of a patient with pancreatic neuroendocrine tumor.
Leuk Lymphoma. 2015;56(8):2468-9. doi: 10.3109/10428194.2014.999327. Epub 2015 Jan 21.
2
DNA repair enzyme expression and differential response to temozolomide in a patient with both glioblastoma and metastatic pancreatic neuroendocrine tumor.一名患有胶质母细胞瘤和转移性胰腺神经内分泌肿瘤的患者的DNA修复酶表达及对替莫唑胺的差异反应
J Clin Oncol. 2008 Oct 10;26(29):4843-4. doi: 10.1200/JCO.2008.18.1776. Epub 2008 Sep 8.
3
Exceptional Responses After Cessation of Therapy With Alkylating Agents for Pancreatic Neuroendocrine Tumors.烷化剂治疗胰腺神经内分泌肿瘤停药后的显著反应
Pancreas. 2020 Jan;49(1):e14-e16. doi: 10.1097/MPA.0000000000001451.
4
Cytotoxic chemotherapy for pancreatic neuroendocrine tumors.用于胰腺神经内分泌肿瘤的细胞毒性化疗
J Hepatobiliary Pancreat Sci. 2015 Aug;22(8):628-33. doi: 10.1002/jhbp.257. Epub 2015 May 3.
5
O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors.O6-甲基鸟嘌呤DNA甲基转移酶状态不能预测高分化胰腺神经内分泌肿瘤对烷化剂的反应或耐药性。
Pancreas. 2017 Jul;46(6):758-763. doi: 10.1097/MPA.0000000000000842.
6
Treatment-related myelodysplastic syndrome after temozolomide use in a child: first report.儿童使用替莫唑胺后发生的治疗相关骨髓增生异常综合征：首例报告
J Pediatr Hematol Oncol. 2008 Nov;30(11):857-9. doi: 10.1097/MPH.0b013e318182e74f.
7
O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors.神经内分泌肿瘤患者中O6-甲基鸟嘌呤DNA甲基转移酶缺乏与基于替莫唑胺治疗的反应
Clin Cancer Res. 2009 Jan 1;15(1):338-45. doi: 10.1158/1078-0432.CCR-08-1476.
8
Targeting neuroendocrine tumor: mixing standard options with novel therapies.靶向神经内分泌肿瘤：将标准治疗方案与新型疗法相结合。
Target Oncol. 2012 Sep;7(3):151-2. doi: 10.1007/s11523-012-0231-z. Epub 2012 Aug 24.
9
MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors.O-甲基鸟嘌呤-DNA甲基转移酶（MGMT）表达可预测胰腺神经内分泌肿瘤对替莫唑胺的反应。
Endocr Relat Cancer. 2016 Aug;23(8):625-33. doi: 10.1530/ERC-16-0117. Epub 2016 Jun 28.
10
High risk of myelodysplastic syndrome and acute myeloid leukemia after 177Lu-octreotate PRRT in NET patients heavily pretreated with alkylating chemotherapy.在接受过大量烷化剂化疗预处理的神经内分泌肿瘤（NET）患者中，177Lu-奥曲肽肽受体放射性核素治疗（PRRT）后发生骨髓增生异常综合征和急性髓系白血病的风险较高。
Endocr Relat Cancer. 2016 May;23(5):L17-23. doi: 10.1530/ERC-15-0543. Epub 2016 Mar 1.
Zotero 插件